Market Highlights
Paronychia is a nail disease that is an often-tender fungal infection of the hand or foot where the nail and skin meets. Paronychia is also known as whitlow, mainly it occurs in people who have constantly cold and wet hands, such as dairy farmers, fishermen, bar tenders, cleaners, housewives or people with poor circulation. It is a multifactorial inflammatory reaction of the proximal nail fold to irritants and allergens.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/1716
The global paronychia treatment market is growing rapidly and is expected to continue over the review period. The demand for paronychia treatment is high across the globe. Increasing ratio of infected population enhances the demand for paronychia treatment globally. According to the American Academy of Family Physicians, few key recommendation for the treatment are provided such as ultrasonography can be used to determine the presence of an abscess or cellulitis when it is not clinically evident, The addition of topical steroids to topical antibiotics decreases the time to symptom resolution in acute paronychia. Moreover, chronic paronychia is treated by topical anti-inflammatory agents and avoidance of irritants.
The global paronychia treatment market is expected to grow at a CAGR of 11.7% during the forecast period 2017-2023.
Regional Analysis
The Americas dominate the global paronychia treatment market owing to the presence of major market player and healthcare awareness. Moreover high healthcare spending and increasing government support for research & development leads the growth of the market.
Europe holds the second largest share of the global paronychia treatment market as result of increasing focus of various government and private agencies on the treatment of skin disease. Moreover well-developed healthcare infrastructure and awareness leads the growth of this market.
Asia Pacific is the fastest growing paronychia treatment market across the globe. Rapidly developing economy, increasing healthcare expenditure, and the government’s initiatives for research & development are projected to drive the market in China and India over the forecasted period.
The Middle East and Africa holds the least share of the global market due to limited availability of medical facilities. Along with unavailability of skin specialists and referral is difficult due to geographic distance and availability of travel funds.
Segmentation
The global paronychia treatment market is segmented on the basis of type, application, and end user. On the basis of the type, it is segmented into acute paronychia, chronic paronychia, candidal paronychia, pyogenic paronychia, and others. On the basis of the application, it is segmented into mupirocin ointment, fusidic acid ointment, gentamicin ointment, dicloxacillin and others. On the basis of the end user, it is segmented into hospitals & clinics, dermatology center, and others.
Key Players
Some of the key players in this market are GlaxoSmithKline plc (U.K), Glenmark Generics Ltd. (India), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly Company (U.S.), Jonakayem Pharma Formulation Pvt. Ltd. (India), Fougera Pharmaceuticals Inc. (U.S.), Taro Pharmaceutical Industries Ltd. (U.S.), Perrigo New York, Inc. (U.S.) and others.
Access Sample Report @
https://www.marketresearchfuture.com/reports/paronychia-treatment-market-1716
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Market HighlightsParonychia is a nail disease that is an often-tender fungal infection of the hand or foot where the nail and skin meets.
Paronychia is also known as whitlow, mainly it occurs in people who have constantly cold and wet hands, such as dairy farmers, fishermen, bar tenders, cleaners, housewives or people with poor circulation.
It is a multifactorial inflammatory reaction of the proximal nail fold to irritants and allergens.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/1716The global paronychia treatment market is growing rapidly and is expected to continue over the review period.
Moreover, chronic paronychia is treated by topical anti-inflammatory agents and avoidance of irritants.The global paronychia treatment market is expected to grow at a CAGR of 11.7% during the forecast period 2017-2023.Regional AnalysisThe Americas dominate the global paronychia treatment market owing to the presence of major market player and healthcare awareness.
Moreover high healthcare spending and increasing government support for research & development leads the growth of the market.Europe holds the second largest share of the global paronychia treatment market as result of increasing focus of various government and private agencies on the treatment of skin disease.
Moreover well-developed healthcare infrastructure and awareness leads the growth of this market.Asia Pacific is the fastest growing paronychia treatment market across the globe.
Nail infection paronychiaParonychia of the finger (according to ICD 10 code L03.0) occurs in adults and children.
It is caused by mechanical, chemical factors, contact dermatitis, onychomycosis, eczema, psoriasis.Depending on the nature and severity of the inflammatory process, the following types of paronychia are distinguished:Simple.
In places where the pus accumulates, the skin acquires a yellow tint, when pressed, pain is felt.Ulcerative.
But, on the other hand, the lack of blood supply means the lack of local protection from external foreign bodies, irritants, pathogenic agents.
These professions include cleaners, laundry workers who are constantly in contact with water, powders, weak alkalis, acids, detergents, and household cleaning agents.Also at risk are professions related to the kitchen, cooks, bartenders, dishwashers.
At-risk are professional swimmers, whose hands and feet are in constant contact with water and pool disinfectants.With the constant action of aggressive substances, the protective barrier of the nail is gradually destroyed, which leads to inflammation.Chronic paronychia is common in people with diabetes mellitus, chronic skin conditions such as eczema and psoriasis.
The new report by Expert Market Research titled, ‘Global Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global ABSSSI market, assessing the market based on its segments like infection type, route of administration, distribution channel, and major regions like Asia Pacific, Europe, North America, Middle East and Africa and Latin America.
The sample report shall be delivered to you within 24 hours.Request a free sample copy in PDF or view the report summary@https://www.expertmarketresearch.com/reports/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-market/requestsampleThe key highlights of the report include:Market Overview (2021-2026)Historical Market Size (2020): USD 9.3 BillionForecast CAGR (2021-2026): 7%Forecast Market Size (2026): USD 14 BillionThe growth of global ABSSSI is driven by the rising prevalence of skin infections.
Additionally, the developing antibiotic resistance in pathogenic bacteria, and mutations resulting in the newer strains is expected to drive the demand for the ABSSI Market.
Further the government spending on healthcare and infrastructure will propel the market in the forecast period.Industry Definition and Major SegmentsABSSSI are mild or severe forms infections caused by pathogens like streptococcus pyogenes and Staphylococcus aureus.
These drugs are pathogen specific and may require surgical excision of lesion in extreme cases.Explore the full report with the table of contents@https://www.expertmarketresearch.com/reports/acute-bacterial-skin-and-skin-structure-infections-absssi-treatment-marketThe acute bacterial skin and skin structure infections (ABSSSI) treatment industry can be segmented by infection type:Hospital-acquired ABSSSICommunity-acquired ABSSSIOthersIt may be differentiated on the basis of route of administration:OralParenteralThe industry may be classified on the basis of distribution channel:Hospital PharmacyRetail PharmacyOnlineOthersLatest Global News on Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Treatment Market@https://www.expertmarketresearch.com/pressrelease/global-absssi-treatment-marketOn the basis of regional markets, the industry is divided into:1 North America1.1 United States of America1.2 Canada2 Europe2.1 Germany2.2 United Kingdom2.3 France2.4 Italy2.5 Others3 Asia Pacific3.1 China3.2 Japan3.3 India3.4 ASEAN3.5 Others4 Latin America4.1 Brazil4.2 Argentina4.3 Mexico4.4 Others5 Middle East & Africa5.1 Saudi Arabia5.2 United Arab Emirates5.3 Nigeria5.4 South Africa5.5 OthersMarket TrendsRegionally, North America is the largest shareholder in the global ABSSSI market, due to the presence of a robust healthcare system.
This can be attributed to the rapidly advancing healthcare sector, increasing population, and growing awareness about various skin aliments.Key Market PlayersThe major players in the market are Debiopharm International SA, Melinta Therapeutics, Inc., Paratek Pharmaceuticals, Inc., GlaxoSmithKline plc, and a few others.
